These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 33772854)

  • 21. The elderly patient with low eGFR: beyond the numbers.
    Azar M
    R I Med J (2013); 2014 Dec; 97(12):19-23. PubMed ID: 25463622
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comments on 'KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease'.
    Andrassy KM
    Kidney Int; 2013 Sep; 84(3):622-3. PubMed ID: 23989362
    [No Abstract]   [Full Text] [Related]  

  • 23. Guidelines for glycemic control and individualized targets.
    Skolnik N
    JAMA; 2010 Sep; 304(10):1069; author reply 1069-70. PubMed ID: 20823431
    [No Abstract]   [Full Text] [Related]  

  • 24. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A; Clase CM; Acott P; Battistella M; Bello A; Feltmate P; Grill A; Karsanji M; Komenda P; Madore F; Manns BJ; Mahdavi S; Mustafa RA; Smyth A; Welcher ES
    Am J Kidney Dis; 2015 Feb; 65(2):177-205. PubMed ID: 25511161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Managing diabetes in hospitalized patients with chronic kidney disease.
    Iyer SN; Tanenberg RJ
    Cleve Clin J Med; 2016 Apr; 83(4):301-10. PubMed ID: 27055204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic Kidney Disease in Diabetes: Guidelines from KDIGO.
    Khunti K; de Boer IH; Rossing P
    Am Fam Physician; 2021 Jun; 103(11):698-700. PubMed ID: 34060786
    [No Abstract]   [Full Text] [Related]  

  • 27. Association Between Routine Nephropathy Monitoring and Subsequent Change in Estimated Glomerular Filtration Rate in Patients With Diabetes Mellitus: A Japanese Non-Elderly Cohort Study.
    Ono S; Ono Y; Koide D; Yasunaga H
    J Epidemiol; 2020 Aug; 30(8):326-331. PubMed ID: 31204363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of diabetes in patients with end-stage kidney disease.
    Zuber K
    JAAPA; 2012 Nov; 25(11):26-9. PubMed ID: 23620920
    [No Abstract]   [Full Text] [Related]  

  • 29. Change in HbA1c as a measure of quality of diabetes care.
    Spitz AF; Kanani H
    Diabetes Care; 2006 May; 29(5):1183-4; discussion 1184-5. PubMed ID: 16644669
    [No Abstract]   [Full Text] [Related]  

  • 30. Glycaemic control and antidiabetic therapy in patients with diabetes mellitus and chronic kidney disease - cross-sectional data from the German Chronic Kidney Disease (GCKD) cohort.
    Busch M; Nadal J; Schmid M; Paul K; Titze S; Hübner S; Köttgen A; Schultheiss UT; Baid-Agrawal S; Lorenzen J; Schlieper G; Sommerer C; Krane V; Hilge R; Kielstein JT; Kronenberg F; Wanner C; Eckardt KU; Wolf G;
    BMC Nephrol; 2016 Jun; 17(1):59. PubMed ID: 27286816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypertension: KDIGO BP guidelines--more individualized, less prescriptive.
    Agarwal R
    Nat Rev Nephrol; 2013 Mar; 9(3):131-3. PubMed ID: 23381373
    [No Abstract]   [Full Text] [Related]  

  • 32. Managing diabetes in hemodialysis patients: observations and recommendations.
    Shrishrimal K; Hart P; Michota F
    Cleve Clin J Med; 2009 Nov; 76(11):649-55. PubMed ID: 19884294
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Diabetes mellitus, company agreements, guidelines, EBM, audit and daily practice].
    Dalla Via A
    Recenti Prog Med; 2013 Sep; 104(9):506. PubMed ID: 24121949
    [No Abstract]   [Full Text] [Related]  

  • 34. Options for intensifying diabetes treatment.
    Reid TS
    J Fam Pract; 2011 Sep; 60(9 Suppl):S7-10. PubMed ID: 21912777
    [No Abstract]   [Full Text] [Related]  

  • 35. Targets for glycated haemoglobin. Glycated haemoglobin targets are attainable.
    Home PD
    BMJ; 1995 Jul; 311(6998):189; author reply 190. PubMed ID: 7677877
    [No Abstract]   [Full Text] [Related]  

  • 36. Agents for the treatment of diabetes mellitus.
    O'Mara NB
    Semin Dial; 2010; 23(5):475-9. PubMed ID: 21069919
    [No Abstract]   [Full Text] [Related]  

  • 37. National primary care guidelines for England: impact on chronic kidney disease prevention in South Asian populations.
    Wilkinson E; Randhawa G; Roderick P; Rehman T; Abubacker T
    J Nephrol; 2012; 25(5):661-71. PubMed ID: 21983987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Guidelines and clinical practice at the primary level of healthcare in patients with type 2 diabetes mellitus with and without kidney disease in five European countries.
    Eder S; Leierer J; Kerschbaum J; Rosivall L; Wiecek A; de Zeeuw D; Mark PB; Heinze G; Rossing P; Heerspink HL; Mayer G
    Diab Vasc Dis Res; 2019 Jan; 16(1):47-56. PubMed ID: 30238781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Too many notes: up and down the scales of diabetes therapy.
    Vinik A
    Clin Ther; 2007 Jun; 29(6 Pt 1):1227-35. PubMed ID: 18036386
    [No Abstract]   [Full Text] [Related]  

  • 40. [Different strategies in prediabetes, new and long-time diabetes. What therapy for what diabetics?].
    Stiefelhagen P
    MMW Fortschr Med; 2010 Jan; 152(3):12-4, 16. PubMed ID: 20333958
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.